Wednesday, December 31, 2008
New therapy for genetic heart disease
"Long-term use of the hypertension drug candesartan may reduce symptoms of heart disease, researchers in the Czech Republic say. Study leader Dr. Jiri Krupicka of Na Homolce Hospital in Prague, Czech Republic, conducted a double-blind, placebo-controlled, randomized study on the long-term administration of candesartan in patients with hypertrophic cardiomyopathy -- a genetic heart condition that thickens the heart muscle. The findings are published in the January issue of The Journal of Molecular Diagnostics"
Labels: Candesartan Czech Republic